Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2023.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 5, 2023.
‘Ridiculous’ site-based hitches mar Biovie phase III in Alzheimer’s
BioWorld
For the second time this week, a contract research organization has come under fire for trial-conduct issues – criticism leveled most recently by Biovie Inc.,...
Waging the losing battle: Altimmune takes on challengers as Pfizer falls back
BioWorld
Altimmune Inc.’s peptide-based glucagon-like peptide-1/glucagon dual receptor agonist pemvidutide hiccupped in a phase I study earlier this year but has bounced...
Japan approves first self-amplifying mRNA COVID-19 vaccine from CSL, Arcturus
BioWorld
In a global first, Japan's Ministry of Health, Labor and Welfare has approved CSL Ltd.’s and Arcturus Therapeutics Inc.’s self-amplifying messenger RNA (sa-mRNA)...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Subscribe